Vitamins that may be helpful
Many years ago, researchers studied the effects of vitamin E supplementation in reducing symptoms of
menopause. Most,16 17 18 19 20 but not
all,21 studies found vitamin E to be helpful. Many doctors suggest that women going
through menopause take 800 IU per day of vitamin E for a trial period of at least three months
to see if symptoms are reduced. If helpful, this amount may be continued. Using lower amounts
for less time has led to statistically significant changes, but only marginal clinical
improvement.22
In 1964, a preliminary trial reported that 1,200 mg each of vitamin C and the flavonoid hesperidin taken over the course of the day
helped relieve hot flashes.23 Although placebo effects are strong in women with hot
flashes, other treatments used in that trial failed to act as effectively as the
flavonoid/vitamin C combination. Since then, researchers have not explored the effects of
flavonoids or vitamin C in women with menopausal symptoms.
The mineral boron is known to affect
estrogen metabolism. In one double-blind trial using 2.5 mg of boron per day for two months,
hot flashes and night sweats worsened in 21 of 43 women, but the same symptoms improved in ten
others.24 Women who are experiencing hot flashes or night sweats that have been
diagnosed as menopausal symptoms and who are also supplementing boron (sometimes found in
significant amounts in osteoporosis formulas
and multivitamin-mineral supplements) should
consider discontinuing use of boron-containing supplements to see if the severity of their
symptoms is reduced.
Aging in women is characterized by a progressive decline in blood DHEA
(dehydroepiandrosterone) and DHEA-sulfate (DHEAS) levels. These levels can be restored with DHEA supplementation. This process also improves
the response of some brain chemicals, called endorphins, to certain drugs.25 These
endorphins are involved in sensations of pleasure and pain; improving their response may explain why DHEA
has an effect on mood symptoms associated with menopause. In one double-blind trial, however,
menopausal women who took 50 mg of DHEA per day for three months had no improvement in
symptoms compared with women taking placebo.26 Further study is needed to validate
a role for DHEA in the management of menopausal symptoms.
Natural progesterone supplementation has
been anecdotally linked to reduction in symptoms of menopause.27 28
29 In one trial, natural progesterone was found to have no independent effect on
symptoms, and synthetic progestins were found
to increase breast tenderness.30 However, a double-blind trial found that topical
administration of natural progesterone cream led to a reduction in hot flashes in 83% of
women, compared with improvement in only 19% of those given placebo.31 Preliminary
research has found that oral, micronized progesterone therapy is associated with improved
quality of life among postmenopausal women. However, oral micronized progesterone is available
only by prescription in the United States.32 Hot flashes, anxiety,
depression, sleep problems, and sexual functioning were among the symptoms improved in a
majority of women surveyed. Synthetic progestins, also available only by prescription, have
reduced symptoms of menopause.33 34 35
Progesterone is a hormone and, as such, concerns about its inappropriate use (i.e., as an
over-the-counter supplement) have been raised. The amount of progesterone in commercially
available creams varies widely, and the progesterone content is not listed on the label
because the creams are legally regulated as cosmetics, not dietary supplements. Therefore, a
physician should be consulted before using these hormone-containing creams as supplements.
Although few side effects have been associated with topical progesterone creams, skin
reactions may occur in some users. Effects of natural progesterone on breast cancer risk remain unclear; research has
suggested both increased and reduced risk.
Are there any side effects or interactions?
Refer to the individual supplement for information about any side effects or interactions.
Herbs that may be helpful
Some, but not all, double-blind trials support the usefulness of black cohosh for women with hot flashes associated
with menopause.36 In a three-month study of postmenopausal women, 40 mg per day of
an extract of black cohosh was as effective as estrogen therapy in the treatment of hot
flashes.37 A review of eight trials concluded black cohosh to be both safe and
effective.38 However, one double-blind trial found that black cohosh is ineffective
as a treatment for menopausal symptoms.39 Many doctors recommend 20 mg of a highly
concentrated extract taken twice per day; 2 to 4 ml of tincture three times per day may also
be used.
In a double-blind study of postmenopausal women who were experiencing psychological
symptoms, a combination of black cohosh and St. John's wort was significantly more effective
than a placebo in improving both menopausal symptoms and depression. The product used in this study contained
(per tablet) black cohosh standardized to 1 mg of triterpene glycosides and St. John's wort
standardized to 0.25 mg of hypericin. The amount taken was two tablets twice a day for eight
weeks, followed by one tablet twice a day for eight weeks.40
A variety of herbs with weak estrogen-like actions similar to the effects of soy have
traditionally been used for women with menopausal symptoms.41 These herbs include
licorice, alfalfa, and red clover. In a double-blind trial, a formula
containing tinctures of licorice, burdock, dong quai, wild yam, and motherwort (30 drops three times daily) was found to
reduce symptoms of menopause.42 No effects on hormone levels were detected in this
study. In a separate double-blind trial, supplementation with dong quai (4.5 grams three times
daily in capsules) had no effect on menopausal symptoms or hormone levels.43 A
double-blind trial using a standardized extract of subterranean clover (Trifolium
subterraneum), a relative of red clover,
containing 40 mg isoflavones per tablet did not impact symptoms of menopause, such as hot
flashes, though it did improve function of the arteries.44 An extract of red
clover, providing 82 mg of isoflavones per day, also was ineffective in a 12-week double-blind
study.45 In another double-blind study, however, administration of 80 mg of
isoflavones per day from red clover reduced the frequency of hot flashes in postmenopausal
women. The benefit was noticeable after 4 weeks of treatment and became more pronounced after
a total of 12 weeks.46
Sage may reduce excessive perspiration due
to menopausal hot flashes during the day or at night.47 It is believed this is
because sage directly decreases production of sweat. In a preliminary study, supplementation
with a product containing extracts of the leaves of sage and alfalfa resulted in complete
elimination of hot flushes and night sweats in 20 of 30 women, with varying degrees of
improvement in the other ten cases.48
Blue vervain (Verbene hastata). is a traditional herb for menopause; however,
there is no research to validate this use. Tincture has been recommended at an amount of
5–10 ml three times per day.
Preliminary evidence suggests that supplementation with St. John’s wort extract (300 mg three times
daily for 12 weeks) may improve psychological symptoms, including sexual well-being, in
menopausal women.49
A double-blind trial found that Asian
ginseng (200 mg per day of standardized extract) helped alleviate psychological symptoms
of menopause, such as depression and anxiety, but did not decrease physical symptoms, such
as hot flashes or sexual dysfunction, in postmenopausal women who had not been treated with
hormones.50
Warning: Kava should only be taken with medical supervision. Kava is
not for sale in certain parts of the world.
In a double-blind trial, a standardized
kava extract was found to be effective at reducing anxiety and other symptoms associated with
menopause.51 The study used 100 mg of kava extract standardized to contain 70%
kava-lactones, three times per day. Most commercially available kava extracts contain up to
35% kava-lactones. In another study, administration of kava enhanced the anti-anxiety effect
of hormone replacement therapy in postmenopausal women.52
Are there any side effects or interactions?
Refer to the individual herb for information about any side effects or interactions.
1. Baird DD, Umbach DM, Landsedell L, et al. Dietary intervention study
to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol
Metab 1995;80:1685–90.
2. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy
protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin
Nutr 1994;60:333–40.
3. Knight DC, Eden JA. A review of the clinical effects of
phytoestrogens. Obstet Gynecol 1996;87:897–904 [review].
4. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary
soy supplementation on hot flushes. Obstet Gynecol 1998;91:6–11.
5. Albertazzi P, Pansini F, Bottazzi M, et al. Dietary soy
supplementation and phytoestrogen levels. Obstet Gynecol 1999;94:229–31.
6. Brezinski A, Adlercreutz H, Shaoul R, et al. Short-term effects of
phytoestrogen-rich diet on postmenopausal women. Menopause 1997;4:89–94.
7. Han KK, Soares JM Jr, Haidar MA, et al. Benefits of soy isoflavone
therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002;99:389–94.
8. Kaari C, Haidar MA, Junior JMS, et al. Randomized clinical trial
comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study.
Maturitas 2006;53:49–58.
9. Welty FK, Lee KS, Lew NS, et al. The association between soy nut
consumption and decreased menopausal symptoms. J Womens Health
2007;16:361–9.
10. Casini ML, Marelli G, Papaleo E, et al. Psychological assessment of
the effects of treatment with phytoestrogens on postmenopausal women: a randomized,
double-blind, crossover, placebo-controlled study. Fertil Steril
2006;85:972–8.
11. Ivarsson T, Spetz AC, Hammar M. Physical exercise and vasomotor
symptoms in postmenopausal women. Mauritas 1998;29:139–46.
12. Hammar M, Berg G, Lindgren R. Does physical exercise influence the
frequency of postmenopausal hot flushes? Acta Obstet Gynecol Scand
1990;69:409–12.
13. Slaven L, Lee C. Mood and symptom reporting among middle-aged women:
the relationship between menopausal status, hormone replacement therapy, and exercise
participation. Health Psychol 1997;16:203–8.
14. Staropoli CA, Flaws JA, Bush TL, Moulton AW. Predictors of menopausal
hot flashes. J Womens Health 1998;7:1149–55.
15. Greenberg G, Thompson SG, Meade TW. Relation between cigarette
smoking and use of hormonal replacement therapy for menopausal symptoms. J Epidemiol
Community Health 1987;41:26–9.
16. Perloff WH. Treatment of the menopause. Am J Obstet Gynecol
1949;58:684–94.
17. Gozan HA. The use of vitamin E in treatment of the menopause. NY
State J Med 1952;52:1289.
18. Christy CJ. Vitamin E in menopause: Preliminary report of
experimental and clinical study. Am J Obstet Gynecol 1945:50:84.
19. Finkler RS. The effect of vitamin E in the menopause. J Clin
Endocrinol Metab 1949;9:89–94.
20. Rubenstein BB. Vitamin E diminishes the vasomotor symptoms of
menopause. Fed Proc 1948;7:106 [abstract].
21. Blatt MHG, Weisbader H, Kupperman HS. Vitamin E and climacteric
syndrome: failure of effective control as measured by menopausal index. Arch Intern
Med 1953;91:792–9.
22. Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of
vitamin E for hot flashes in breast cancer survivors. J Clin Oncol
1998;16:495–500.
23. CJ Smith. Non-hormonal control of vaso-motor flushing in menopausal
patients. Chicago Med 1964;67:193–5.
24. Nielsen FH, Penland JG. Boron supplementation of per-menopausal women
affects boron metabolism and indices associated with macromineral metabolism, hormonal status
and immune function. J Trace Elements Exp Med 1999;12:251–61.
25. Stomati M, Rubino S, Spinetti A, et al. Endocrine, neuroendocrine and
behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal
women. Gynecol Endocrinol 1999;13:15–25.
26. Barnhart KT, Freeman E, Grisso JA, et al. The effect of
dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine
profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol
Metab 1999;84:3896–902.
27. Lee JR. Natural Progesterone. The multiple roles of a remarkable
hormone. Sebastipol, CA: BLL Publishing, 1993, 31–7.
28. Gaby AR. Commentary. Nutr Healing
1996;June:1,10–1.
29. Wright JV. Hormones for menopause. Nutr Healing
1996;June:1–2,9.
30. Greendale GA, Reboussin BA, Hogan P, et al. Symptom relief and side
effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin
Interventions Trial. Obstet Gynecol 1998;92:982–8.
31. Leonetti HB, Long S, Anasti JM. Transdermal progesterone cream for
vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol
1999;94:225–8.
32. Fitzpatrick LA, Pace C, Wiita B. Comparison of regimens containing
oral micronized progesterone or medroxyprogesterone acetate on quality of life in
postmenopausal women: a cross-sectional survey. J Women’s Health Gender-Based
Med 2000;9:381–7.
33. Bullock JL, Massey FM, Gambrell RD Jr. Use of medroxyprogesterone
acetate to prevent menopausal symptoms. Obstet Gynecol 1975;46:165–8.
34. Morrison JC, Martin DC, Blair RA, et al. The use of
medroxyprogesterone acetate for relief of climateric symptoms. Am J Obstet Gynecol
1980 138:99–104.
35. Schiff I, Tulchinsky D, Cramer D, Ryan KJ. Oral medroxyprogesterone
in the treatment of postmenopausal symptoms. JAMA 1980;244:1443–5.
36. Liske E. Therapeutic efficacy and safety of Cimicifuga
racemosa for gynecological disorders. Advances Therapy 1998;15:45–53.
37. Nappi RE, Malavasi B, Brundu B, Facchinetti F. Efficacy of
Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose
transdermal estradiol. Gynecol Endocrinol 2005;20:30–5.
38. Lieberman S. A review of the effectiveness of Cimicifuga
racemosa (black cohosh) for the symptoms of menopause. J Womens Health
1998;7:525–9.
39. Newton KM, Reed SD, LaCroix AZ, et al. Treatment of vasomotor
symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a
randomized trial. Ann Intern Med 2006;145:869–79.
40. Uebelhack R, Blohmer JU, Graubaum HJ, et al. Black cohosh and St.
John's wort for climacteric complaints: a randomized trial. Obstet Gynecol
2006;107:247–55.
41. Crawford AM. The Herbal Menopause Book. Freedom, CA:
Crossing Press, 1996.
42. Hudson TS, Standish L, Breed C, et al. Clinical and endocrinological
effects of a menopausal botanical formula. J Naturopathic Med
1997;7(1):73–7.
43. Hirata JD, Swiersz LM, Zell B, et al. Does dong quai have estrogenic
effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil
Steril 1997;68:981–6.
44. Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover
improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin
Endocrinol Metab 1999;84:895–8.
45. Tice JA, Ettinger B, Ensrud K, et al. Phytoestrogen supplements for
the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized
controlled trial. JAMA 2003;290:207–14.
46. van de Weijer PHM, Barentsen R. Isoflavones from red clover
(Promensil®) significantly reduce menopausal hot flush symptoms compared with placebo.
Maturitas 2002;42:187–93.
47. Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL:
CRC Press, 1985, 420–1 [review].
48. De Leo V, Lanzetta D, Cazzavacca R, Morgante G. [Treatment of
neurovegetative menopausal symptoms with a phytotherapeutic agent] [Article in Italian]
Minerva Ginecol 1998;50:207–11.
49. Grube B, Walper A, Wheatley D. St. John’s Wort extract:
efficacy for menopausal symptoms of psychological origin. Adv Ther
1999;16:177–86.
50. Wiklund IK, Mattson LA, Lindgren R, et al. Effects of a standardized
ginseng extract on quality of life and psychological parameters in symptomatic postmenopausal
women: a double-blind, placebo-controlled trial. Int J Clin Pharm Res
1999;19:89–99.
51. Warnecke G. Psychosomatic dysfunctions in the female climacteric.
Clinical effectiveness and tolerance of kava extract WS 1490. Fortschr Med
1991;119–22 [in German].
52. De Leo V, la Marca A, Morgante G, et al. Evaluation of combining kava
extract with hormone replacement therapy in the treatment of postmenopausal anxiety.
Maturitas 2001;39:185–8.
53. Toriizuka K, Okumura M, Iijima K, et al. Acupuncture inhibits the
decrease in brain catecholamine contents and the impairment of passive avoidance task in
ovariectomized mice. Acupunct Electrother Res 1999;24:45–57.
54. Wyon Y, Lindgren R, Hammar M, Lundeberg T. Acupuncture against
climacteric disorders? Lower number of symptoms after menopause. Lakartidningen
1994;91:2318–22 [in Swedish].
55. Popivanov P. Menopausal indices as criteria for the effectiveness of
acupuncture treatment of the climacteric syndrome. Vutr Boles 1983;22:110–3 [in
Bulgarian].
56. Kraft K, Coulon S. Effect of a standardized acupuncture treatment on
complaints, blood pressure and serum lipids of hypertensive, postmenopausal women. A
randomized, controlled clinical study. Forsch Komplementarmed 1999;6:74–9 [in
German].
57. Lianzhong W, Xin Z. 300 cases of menopausal syndrome treated by
acupuncture. J Trad Chin Med 1998;18:259–62.